Graeme Smith, CSO and Helen Robinson, VP Biology attending the 5th Digital DDR, ATR, & PARP Summit – 25/26 January 2022

Join Graeme Smith our CSO and Helen Robinson, VP of Biology during the 5^th Digital DDR, ATR & PARP Inhibitors Summit from January 25-27. The summit will highlight the new and novel next-generation DDR therapeutics, biomarker understanding and optimal treatment combinations for an array of cancer indications. Join us to learn more!